As a proof of our concept that STO-1 elicits an M2→M1 reprogramming of tumor-associated microglia and macrophages (TAMs), we generated GBM tumors and then subjected the GBM-harboring mice to a short-term daily vehicle or drug treatment. The gene discussed is NCBP1; the disease is glioblastoma.